Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA, a biotech firm focused on RNA therapeutics and immunotherapy, announced the final results of its rights issue, which fell short of the minimum secured level, prompting the exercise of a NOK 1.5 million convertible bond commitment by Atlas. Circio is advancing its proprietary circVec technology for genetic medicine and is testing its cancer vaccine TG01 in several clinical trials. These developments indicate Circio’s potential impact on DNA and virus-based therapeutics and cancer treatment.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
